The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization
- 1 March 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (3) , 647-653
- https://doi.org/10.1016/s0735-1097(98)00620-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Myonecrosis After Revascularization ProceduresJournal of the American College of Cardiology, 1998
- Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary InterventionJAMA, 1997
- Periprocedural Cardiac Marker Elevation After Percutaneous Coronary Artery RevascularizationImportance and ImplicationsJAMA, 1997
- Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary InterventionsCirculation, 1996
- Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventionsAmerican Heart Journal, 1996
- Predictors of late mortality following ablative new-device angioplasty in native coronary arteriesJournal of the American College of Cardiology, 1996
- Post-intervention cardiac enzyme elevations: Prognostic significance in IMPACT IIJournal of the American College of Cardiology, 1996
- Long-term Outcome of Transient, Uncomplicated In-Laboratory Coronary Artery ClosureCirculation, 1995
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994